Home » Topics » Disease categories and therapies » Immune

Immune
RSS

HuM291 appears to induce transplant tolerance via apoptosis of activated T-cells

Sep. 14, 2000

DNA vaccine encoding C3d enhances immune response to influenza

Sep. 13, 2000

SDZ-RAD continues to shine as a potential agent for transplantation

Sep. 13, 2000

Immunosuppressive effects of new peptide confirmed; additional hypolipidemic effects seen

Sep. 12, 2000

ISAtx-247 as a potentially improved alternative to ciclosporin

Sep. 12, 2000

Aquila awarded grant to develop vaccines against S. aureus

Sep. 12, 2000

Grant to study 5D12 in prevention of transplant rejection awarded to Tanox

Sep. 8, 2000

Cantab finalizes DISC-HSV agreement with Glaxo Wellcome

Sep. 7, 2000

New cinnamamide derivatives and their use described by Tsumura

Sep. 7, 2000

New JT compounds exert immunostimulating, antiviral and antitumor activity

Sep. 7, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...